Novo Nordisk A/S (NONOF)
Company Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide.
It operates in two segments, Diabetes and Obesity care, and Biopharm.
The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases.
The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy.
The company collaboration agreements with Gilead Sciences, Inc.
Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease.
The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
| Country | DK |
| IPO Date | May 7, 2010 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 76,302 |
| CEO | Lars Fruergaard Jorgensen |
Contact Details
Address: Novo Allé 1 Bagsvaerd, DK | |
| Website | https://www.novonordisk.com |
Stock Details
| Ticker Symbol | NONOF |
| Exchange | PNK |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0000353278 |
| CUSIP Number | n/a |
| ISIN Number | DK0062498333 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Lars Fruergaard Jorgensen | President, Chief Executive Officer & Member of Management Board |
| Karsten Munk Knudsen | Executive Vice President, Chief Financial Officer & Member of the Management Board |
| David S. Moore | Executive Vice President of US Operations & Global Business Development and Member of Management Board |
| Dr. Marcus Schindler Ph.D. | EVice President of Research & Early Development, Chief Scientific Officer & Member of the Management Board |
| Dr. Martin Holst Lange | Executive Vice President of Development & Member of the Management Board |
| Henrik Ehlers Wulff | Executive Vice President of Product Supply, Quality & IT and Member of the Management Board |
| Jacob Martin Wiborg Rode | Head of Investor Relations |
| Ludovic Helfgott | Executive Vice President of Product & Portfolio Strategy and Member of Management Board |
| Maziar Mike Doustdar | Executive Vice President of International Operations & Member of the Management Board |
| Tania Sabroe | EVice President of People, Organisation and Communication & Member of Management Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 03, 2025 | 6-K | Filing |
| Mar 31, 2025 | 6-K | Filing |
| Mar 10, 2025 | 6-K | Filing |
| Feb 27, 2025 | 6-K | Filing |
| Feb 10, 2025 | IRANNOTICE | Filing |
| Feb 07, 2025 | 6-K | Filing |
| Feb 06, 2025 | 6-K | Filing |
| Feb 05, 2025 | 6-K | Filing |
| Feb 05, 2025 | 6-K | Filing |
| Feb 05, 2025 | 20-F | Filing |